PIASCLEDINE Trademark

Trademark Overview

On Thursday, May 6, 2021, a trademark application was filed for PIASCLEDINE with the United States Patent and Trademark Office. The USPTO has given the PIASCLEDINE trademark a serial number of 90693911. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, February 23, 2024. This trademark is owned by Laboratoires Expanscience. The PIASCLEDINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of osteoarthritis
piascledine

General Information

Serial Number90693911
Word MarkPIASCLEDINE
Filing DateThursday, May 6, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, February 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of osteoarthritis
Translation of Words in MarkThe wording PIASCLEDINE has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLaboratoires Expanscience
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis La Defense Cedex F-92048
FR
Party NameLaboratoires Expanscience
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis La Defense Cedex F-92048
FR

Trademark Events

Event DateEvent Description
Monday, May 10, 2021NEW APPLICATION ENTERED
Monday, August 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, January 10, 2022ASSIGNED TO EXAMINER
Wednesday, January 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 1 FILED
Thursday, September 22, 2022SOU EXTENSION 1 GRANTED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 27, 2023SOU EXTENSION 2 FILED
Monday, March 27, 2023SOU EXTENSION 2 GRANTED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 3 FILED
Monday, September 18, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 20, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 23, 2024SOU EXTENSION 4 GRANTED
Friday, February 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 23, 2024SOU EXTENSION 4 FILED
Wednesday, December 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, February 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

piascledine osteoarthritis treatment preparations pharmaceutical